Nucleus Network (NN) is Australia’s only multi-site dedicated phase I CRO located in Melbourne (80 beds) and Brisbane (62 beds). The facilities are strategically co-located within the Alfred Hospital in Melbourne and the Royal Brisbane and Women’s Hospital in Brisbane. This provides NN with access to a combined population of 7.5 million people. Since 2004, NN has conducted over 750 studies, with 90% of clients being overseas pharmaceutical and biotech companies. NN runs approximately 70 studies per year, with around 30 of these being true first-in-human studies. For more information, contact Michael Watson, firstname.lastname@example.org.